Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 years or older.
- People who have been diagnosed with stomach or gastroesophageal cancer (a type called adenocarcinoma) that has spread to other parts of the body, has come back after treatment, or cannot be removed with surgery.
- People whose tumor tissue has tested positive for a protein called HER2, based on specific lab tests (called IHC 3+, or IHC 2+ with a second confirming test called ISH).
- People who have already received a medicine called Trastuzumab Deruxtecan as their third or later round of cancer treatment.
Who may not be able to join:
- People whose cancer has tested negative for the HER2 protein.
- People who have not given their consent to take part in the study.
- People who received Trastuzumab Deruxtecan as their first or second round of cancer treatment as part of another clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: minkyu Jung, Yonsei Cencer center
Phone: 0222278406
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.